[Improvement in anti-hemophilic preparations and its problems. 3. Treatment of hemophilia patients with inhibitors; induction of immune tolerance by a low or intermediate dose regimen].
Iizuka
A
A
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005164:Factor IX / Q000008:administration & dosage* / Q000276:immunology; D005169:Factor VIII / Q000008:administration & dosage* / Q000276:immunology; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007108:Immune Tolerance; D007074:Immunoglobulin G / Q000032:analysis*; D007167:Immunotherapy; D007518:Isoantibodies / Q000032:analysis*
D007074:Immunoglobulin G; D007518:Isoantibodies; D005169:Factor VIII; D005164:Factor IX